Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00368212
Other study ID # R01MH040487
Secondary ID R01MH040487DSIR
Status Completed
Phase Phase 3
First received August 23, 2006
Last updated March 15, 2013
Start date May 2005
Est. completion date July 2008

Study information

Verified date March 2013
Source Brigham and Women's Hospital
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

This study will evaluate the effectiveness of an integrated three-part treatment program in improving the quality of care and treatment outcomes of people with hypochondriasis in primary care settings.


Description:

Hypochondriasis, which is classified as a type of somatoform disorder, is one of the most difficult psychiatric disorders to treat. It is prevalent in primary care settings, and is a major source of suffering for patients and frustration for physicians. People with hypochondriasis tend to become preoccupied with the fear of having a serious disease, despite appropriate medical evaluations and reassurance that indicate otherwise. The disorder usually occurs in episodes lasting from months to years, separated by equally long periods of quiescence. Existing strategies for treating hypochondriasis include psychotherapy, medication treatment, and alternative treatments, such as exercise and electroconvulsive therapy. An effective treatment program should target the needs of both patients and physicians, as well as the structure of the delivery system. Components of such a program have been developed, but have not yet been integrated and tested in a clinical setting. This study will evaluate the effectiveness of an integrated three-part treatment program in improving hypochondriasis treatment and quality of care outcome in primary care settings.

Participants in this 6-month, single-blind study will first undergo baseline assessments. They will then be randomly assigned to partake in either the three-part treatment program or relaxation response training, in which patients are taught to use muscle relaxation techniques to reduce stress. Over the course of the study, participants assigned to the three-part program will attend five self-scheduled, 30-minute sessions of psychoeducational counseling based on cognitive behavioral therapy principles. Sessions will focus on common hypochondriacal cognitive distortions and misunderstandings about symptoms, disease, and medical care. Additionally, the doctors and nurses at the participating hospital will undergo a training program to improve medical management of patients with hypochondriasis. The final component of the program will entail implementing an enhanced role for nurse practitioners to collaborate with primary care physicians in caring for patients with hypochondriasis. Participants assigned to relaxation response training will attend three self-scheduled, 1-hour sessions over the course of the study. They will be provided with an explanation of the physical effects of stress on the body and the purposes of progressive muscle relaxation training. They will then learn a relaxation technique through direct instruction, and will practice between sessions. Participants will also use a 20-minute audio tape to practice once a day, 5 to 7 days a week between clinic visits. All participants will attend self-scheduled follow-up visits 6 and 12 months following the end of treatment.


Recruitment information / eligibility

Status Completed
Enrollment 91
Est. completion date July 2008
Est. primary completion date July 2008
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Has received primary medical care at Harvard Vanguard Medical Associates (HVMA) for at least 12 months prior to study entry

- Expects to continue receiving care from the current primary care physician for at least the next 12 months

- Meets requirement for average hypochondriasis screening score

- Able to speak and read English

- Falls within the top 20% of utilizers of health care services in the HVMA system over the past year

- Has attended no more than one visit to any specialist over the year prior to study entry

Exclusion Criteria:

- Psychiatric illness (e.g., psychosis, dementia, suicidal ideation)

- Somatoform pain disorder or currently receiving treatment for somatoform pain disorder (e.g., relaxation training)

- History of alcohol or substance abuse or dependence within the 12 months prior to study entry

- Terminal medical illness or major medical illness expected to worsen significantly over the next year

- Ongoing symptom-contingent litigation against HVMA

- Monetary compensation for medical disability

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Relaxation response training
The control treatment is relaxation training or attention control. This will be taught in three, 1-hour sessions with a trained therapist.
Psychoeducational counseling
Patients will receive five sessions of psychoeducational counseling from the nurse who works with the primary care physicians. Patients who are interested in continuing treatment or who have not responded to this first treatment step will then be referred for the second step, cognitive behavioral therapy (CBT), for more intensive treatment.

Locations

Country Name City State
United States Harvard Vanguard Medical Associates Boston Massachusetts
United States Harvard Vanguard Medical Associates Cambridge Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Brigham and Women's Hospital National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Whitely Index Measured immediately post-treatment and at Months 6 and 12 post-treatment No
Secondary Health Anxiety Inventory Measured immediately post-treatment and at Months 6 and 12 post-treatment No
Secondary Modified Cognitions Questionnaire Measured immediately post-treatment and at Months 6 and 12 post-treatment No
Secondary Somatic Symptom Inventory Measured immediately post-treatment and at Months 6 and 12 post-treatment No
Secondary Functional Status Questionnaire Measured immediately post-treatment and at Months 6 and 12 post-treatment No
Secondary Client Satisfaction Index Measured immediately post-treatment and at Months 6 and 12 post-treatment No
See also
  Status Clinical Trial Phase
Completed NCT00276887 - Cognitive Behavior Therapy for Somatization Disorder Phase 2
Enrolling by invitation NCT05565352 - Observation of Ketamine Treatment Safety and Tolerability in Adult Psychiatry Clinic Medical University of GdaƄsk Inpatients
Active, not recruiting NCT04847310 - Cost-benefit Evaluation of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care N/A
Completed NCT05611606 - Welfare Benefits in Functional Somatic Disorders
Completed NCT05631860 - Psychological Risk Factors for Functional Somatic Disorders
Completed NCT02151500 - Stress and Health Interview for Primary Care Patients With Medically Unexplained Symptoms N/A
Completed NCT01590992 - Treatment of Globus Sensations With Psychotherapy N/A
Completed NCT00149799 - Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder Phase 3
Terminated NCT02843932 - Subjective Perception of Motor Control During Psychogenic Disorders N/A
Terminated NCT03904784 - School Withdrawal in Adolescents
Recruiting NCT04807933 - Neurovegetative Decoupling in Somatoform Disorders : Biofeedback Interest N/A
Completed NCT01119469 - Comparing Cognitive Therapy and Exposure Therapy in Individuals With Hypochondriasis Phase 3
Recruiting NCT03188861 - Systematic Screening for Comorbid Psychological Conditions in Cardiac ACSC Patients With Multimorbidity in the ED
Recruiting NCT04835103 - Build a Research Clinic for Somatoform Patients N/A
Completed NCT02346071 - Acceptance and Commitment Group Therapy for Adolescents With a Range of Functional Somatic Syndromes N/A
Completed NCT01518647 - Acceptance and Commitment Therapy for Patients With Multi-organ Bodily Distress Syndrome (Stress-4) N/A
Completed NCT01518634 - Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome Phase 2
Recruiting NCT01391897 - Epigenetics of Posttraumatic Stress Disorder and Somatoform Disorders in the Course of Psychotherapy N/A
Completed NCT01924715 - Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study N/A
Completed NCT00130988 - DEPENAS: A Psychosocial Intervention for Patients With Medically Unexplained Symptoms Phase 3